Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€43.60

€43.60

-2.680%
-1.2
-2.680%
€50.00

€50.00

 
15:48 / Tradegate WKN: A2YNT3 / Name: AlzChem / Stock / Software & IT Services / Small Cap /
Latest predictions
12.03.24
50.87%
buy
03.01.24
66.41%
buy
€50.00
28.11.23
80.17%
buy
15.08.23
98.18%
buy
Best running prediction
-
15.08.23
98.18%
buy
Your prediction

AlzChem Group AG Stock

A loss of -2.680% shows a downward development for AlzChem Group AG.
Our community is currently high on AlzChem Group AG with 4 Buy predictions and 0 Sell predictions.
With a target price of 50 € there is a slightly positive potential of 14.68% for AlzChem Group AG compared to the current price of 43.6 €.
Our community identified positive and negative aspects for AlzChem Group AG stock for the coming years. 1 users see the criterium "Revenue growth" as a plus for the AlzChem Group AG stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of AlzChem Group AG in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of AlzChem Group AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
AlzChem Group AG -2.680% -0.665% 11.443% 131.525% 70.992% 78.486% -
Allgeier SE -2.410% -4.604% -8.128% -32.305% -12.850% -20.807% -25.697%
CENIT AG -2.400% 0.000% -3.846% -13.495% 4.167% -11.972% -11.032%
All For One Steeb AG -0.340% -3.311% -0.341% 39.713% 22.947% -4.575% 16.800%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18

Looking at the financials of AlzChem, a company in the Software & IT Services industry, one can observe a positive trend in the company's growth. Net income and total assets have gradually increased over the past three years, which is generally a positive sign. However, a closer examination of various financial aspects is necessary for a comprehensive analysis.

*Pros: *

Growth in total assets: The total assets for AlzChem have experienced consistent growth over the last three years, from €354.3 million in 2020 to €422.8 million in 2022. This growth reflects an improvement in the company's overall financial health.

Comments

systinvest hat das Wertpapier AlzChem Group AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more

News

EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments